Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

853 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial.
Susai SR, Mongan D, Healy C, Cannon M, Nelson B, Markulev C, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Föcking M, Cotter D, Amminger GP. Susai SR, et al. Among authors: nordentoft m. Brain Behav Immun. 2022 Jan;99:147-156. doi: 10.1016/j.bbi.2021.09.018. Epub 2021 Oct 5. Brain Behav Immun. 2022. PMID: 34624483 Free article. Clinical Trial.
Intervention in individuals at ultra-high risk for psychosis: a review and future directions.
McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, Riecher-Rössler A, Klosterkötter J, Ruhrmann S, Schultze-Lutter F, Nordentoft M, Hickie I, McGuire P, Berk M, Chen EY, Keshavan MS, Yung AR. McGorry PD, et al. Among authors: nordentoft m. J Clin Psychiatry. 2009 Sep;70(9):1206-12. doi: 10.4088/JCP.08r04472. Epub 2009 Jun 30. J Clin Psychiatry. 2009. PMID: 19573499 Review.
NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.
Markulev C, McGorry PD, Nelson B, Yuen HP, Schaefer M, Yung AR, Thompson A, Berger G, Mossaheb N, Schlögelhofer M, Smesny S, de Haan L, Riecher-Rössler A, Nordentoft M, Chen EYH, Verma S, Hickie I, Amminger GP. Markulev C, et al. Among authors: nordentoft m. Early Interv Psychiatry. 2017 Oct;11(5):418-428. doi: 10.1111/eip.12260. Epub 2015 Aug 16. Early Interv Psychiatry. 2017. PMID: 26279065 Clinical Trial.
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.
McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EY, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger GP. McGorry PD, et al. Among authors: nordentoft m. JAMA Psychiatry. 2017 Jan 1;74(1):19-27. doi: 10.1001/jamapsychiatry.2016.2902. JAMA Psychiatry. 2017. PMID: 27893018 Free article. Clinical Trial.
Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis.
Hartmann JA, McGorry PD, Schmidt SJ, Amminger GP, Yuen HP, Markulev C, Berger GE, Chen EYH, de Haan L, Hickie IB, Lavoie S, McHugh MJ, Mossaheb N, Nieman DH, Nordentoft M, Riecher-Rössler A, Schäfer MR, Schlögelhofer M, Smesny S, Thompson A, Verma SK, Yung AR, Nelson B. Hartmann JA, et al. Among authors: nordentoft m. Psychother Psychosom. 2017;86(5):292-299. doi: 10.1159/000477551. Epub 2017 Sep 14. Psychother Psychosom. 2017. PMID: 28903120 Free article. Clinical Trial.
Clinical trajectories in the ultra-high risk for psychosis population.
Polari A, Lavoie S, Yuen HP, Amminger P, Berger G, Chen E, deHaan L, Hartmann J, Markulev C, Melville F, Nieman D, Nordentoft M, Riecher-Rössler A, Smesny S, Stratford J, Verma S, Yung A, McGorry P, Nelson B. Polari A, et al. Among authors: nordentoft m. Schizophr Res. 2018 Jul;197:550-556. doi: 10.1016/j.schres.2018.01.022. Epub 2018 Feb 18. Schizophr Res. 2018. PMID: 29463457
Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
Bolt LK, Amminger GP, Farhall J, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Allott KA. Bolt LK, et al. Among authors: nordentoft m. Schizophr Res. 2019 Apr;206:67-74. doi: 10.1016/j.schres.2018.12.013. Epub 2018 Dec 14. Schizophr Res. 2019. PMID: 30558978
853 results